-
Product Insights
NewLikelihood of Approval Analysis for Pleural Effusion
Overview How likely is it that the drugs in Pleural Effusion will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pleural Effusion Overview Pleural Effusion also known as fluid in lungs is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Umedaptanib Pegol in Wet (Neovascular / Exudative) Macular Degeneration
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Umedaptanib Pegol in Wet (Neovascular / Exudative) Macular Degeneration report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Umedaptanib Pegol in Wet (Neovascular / Exudative)...
-
Thematic Analysis
NewGeopolitics – Executive Briefing (First Edition)
Reasons to buy the ‘Geopolitics - Executive Briefing’ report: The report provides in-depth insights into the global geopolitical stance. Explore a global geopolitical risk map highlighting level of severity and a summary on the 2024 elections. Identify the frontline sectors exposed to global geopolitics. The report sheds light on the politics of the major countries that shape geopolitics. How is the ‘Geopolitics - Executive Briefing’ report different from other reports in the market? This executive briefing report explores the drivers...
-
Thematic Analysis
NewUkraine Conflict Impact – Thematic Intelligence
Ukraine Conflict Impact Report Overview The large-scale Russian invasion of Ukraine in February 2022 has dramatically restructured strategic priorities within the global defense sector either by developing innovative defense capabilities, or the re-invigorating previously stagnant market segments. As the geostrategic implications of this conflict continue to reverberate across global markets, the primary lesson learned is the need to upscale production capacity and leverage cost-efficiency across all domains of modern warfare, with investments driving innovation of both technology and operations throughout...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – A2A-04 in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - A2A-04 in Endometrial Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. A2A-04 in Endometrial Cancer Drug Details: A2A-04 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – A2A-04 in Fallopian Tube Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - A2A-04 in Fallopian Tube Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. A2A-04 in Fallopian Tube Cancer Drug Details: A2A-04 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – A2A-04 in Metastatic Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - A2A-04 in Metastatic Ovarian Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. A2A-04 in Metastatic Ovarian Cancer Drug Details: A2A-04 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – A2A-04 in Peritoneal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - A2A-04 in Peritoneal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. A2A-04 in Peritoneal Cancer Drug Details: A2A-04 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – A2A-04 in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - A2A-04 in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. A2A-04 in Triple-Negative Breast Cancer (TNBC) Drug Details: A2A-04 is...
-
Sector Analysis
Denmark Defense Market Size, Trends, Budget Allocation, Regulations, Acquisitions, Competitive Landscape and Forecast to 2028
Denmark Defense Market Report Overview As of 2023, the Denmark defense budget is worth $5.1 billion. The country’s defense budget is set to see high levels of growth, registering a CAGR of more than 4% between 2024 and 2028. The increase in Danish defense expenditure is primarily driven by the government's response to the conflict in Ukraine. Factors expected to accelerate the Denmark's defense market growth during the projected period are rise in the Danish defense sector spending to facilitate...